Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

Hill, Anita, Rother, Russell P., Wang, Xunde, Morris, Jr, Sidney M., Quinn‐Senger, Kerry, Kelly, Richard, Richards, Stephen J., Bessler, Monica, Bell, Leonard, Hillmen, Peter, Gladwin, Mark T. · 2010 · British Journal of Haematology

Abstract

Summary: Pulmonary hypertension (PH) is a common complication of haemolytic anaemia. Intravascular haemolysis leads to nitric oxide (NO) depletion, endothelial and smooth muscle dysregulation, and vasculopathy, characterized by progressive hypertension. PH has been reported in patients with paroxysmal nocturnal haemoglobinuria (PNH), a life‐threatening haemolytic disease. We explored the relationship between haemolysis, systemic NO, arginine catabolism and measures of PH in 73 PNH patients enrolled in the placebo‐controlled TRIUMPH (Transfusion Reduction Efficacy and Safety Clinical Investigation Using Eculizumab in Paroxysmal Nocturnal Haemoglobinuria) study. At baseline, intravascular haemolysis was associated with elevated NO consumption ( P < 0·0001) and arginase‐1 release ( P < 0·0001). Almost half of the patients in the trial had elevated levels (≥160 pg/ml) of N ‐terminal pro‐brain natriuretic peptide (NT‐proBNP), a marker of pulmonary vascular resistance and right ventricular dysfunction previously shown to indicate PH. Eculizumab treatment significantly reduced haemolysis ( P < 0·001), NO depletion ( P < 0·001), vasomotor tone ( P < 0·05), dyspnoea ( P = 0·006) and resulted in a 50% reduction in the proportion of patients with elevated NT‐proBNP ( P < 0·001) within 2 weeks of treatment. Importantly, the significant improvements in dyspnoea and NT‐proBNP levels occurred without significant changes in anaemia. These data demonstrated that intravascular haemolysis in PNH produces a state of NO catabolism leading to signs of PH, including elevated NT pro‐BNP and dyspnoea that are significantly improved by treatment with eculizumab.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2010.08096.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 158

Metadata

Authors
Hill, A., Rother, R. P., Wang, X., Morris, Jr., Quinn‐Senger, K., Kelly, R., Richards, S. J., Bessler, M., Bell, L., Hillmen, P., & Gladwin, M. T.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2010-04-12
Volume
149
Issue
3
Pages
414-425
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2032628053
Cited by
158
References
5
FWCI
5.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. https://app.cochat.ai/papers/10.1111/j.1365-2141.2010.08096.x
The paper
Hill, A., Rother, R. P., Wang, X., Morris, Jr., Quinn‐Senger, K., Kelly, R., Richards, S. J., Bessler, M., Bell, L., Hillmen, P., & Gladwin, M. T. (2010). Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2010.08096.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.